Oracle to acquire data management provider Phase Forward for $685M

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
Phase Forward, a provider of data management technologies for clinical trials and drug safety, has agreed to be acquired by Oracle for approximately $685 million.

The Waltham, Mass.-based Phase Forward management and employees are expected to join San Francisco-based Oracle as part of its health sciences global business unit. The combination is expected to allow researchers, clinical development professionals, physicians, regulators and patients to capture, contribute, access and share data, according to Oracle and Phase Forward.

"The life sciences and healthcare industries are converging as they seek to control costs while accelerating patient-centered innovation," said Neil de Crescenzo, senior vice president and general manager of Oracle’s health sciences unit.

The companies said the transaction is subject to stockholder and regulatory approval and other customary closing conditions and is expected to close in mid-2010.

Justine Varieur Cadet

Related Content

Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.